The current standard of care for men with non-metastatic prostate cancer who are on hormone therapy (ADT) does not include the use of any of the bisphosphonate drugs. Some men might benefit by using them at this stage.
Stand Up To Cancer announced an initiative that will both help scientists understand the emerging coronavirus pandemic and ensure the needs of cancer patients and survivors are being included as the research goes forward.
